Seegene Inc
Contact

Not Available for sale in the United States

  • Real-time
    PCR
  • CE-IVD
    marked

Anyplex™ II
MTB/MDR/XDR Detection

Simultaneous detection of MTB, 25 mutations associated with Multi-Drug Resistance tuberculosis (MDR-TB) and 13 mutations associated with Extensively Drug Resistance tuberculosis (XDR-TB)

Anyplex™ II MTB/MDR/XDR Detection is a multiplex real-time PCR assay that detect Mycobacterium tuberculosis (MTB) with Ct value and identify 38 mutations associated with Drug-Resistance simultaneously. Based on Seegene’s proprietary DPO™ and TOCE™ technologies, this assay performs on multiplex real-time PCR instruments and provide prompt diagnosis and appropriate treatment guideline for tuberculosis control.

Features

Result

The results indicate the detection of MTB infection in the FAM channel, and the rifampicin-resistance mutation in the HEX channel and the Isoniazid-resistance mutation in the Cal Red 610 channel.

Publication

- Pre-Extensively Drug Resistant Tuberculosis (Pre-XDR-TB) among Pulmonary Multidrug Resistant Tuberculosis (MDR-TB) Patients in Bangladesh

- Diagnostic performance of Anyplex II MTB/MDR/XDR for detection of resistance to first and second line drugs in Mycobacterium tuberculosis

- Diagnostic performance of Anyplex II MTB/MDR/XDR for detection of resistance to first and second line drugs in Mycobacterium tuberculosis

- New Anyplex™ II MTB/MDR/XDR kit for detection of resistance mutations in M. tuberculosis cultures

- New Anyplex II MTB/MDR/XDR kit for detection of resistance mutations in M. tuberculosis cultures

- Evaluation of the Diagnostic Performance of Anyplex II MTB/MDR/XDR Detection Assay for Detection and Antimicrobial Susceptibility testing of Mycobacterium tuberculosis from S

Note

[1] The WTC is designed to be exhibited the same result pattern with drug-susceptible M. tuberculosis sample. The WTC reaction should be always performed in each testing run, and the drug-resistant result of unknown samples is analyzed on the basis of the result of WTC.

[2] Multi-Drug Resistance

[3] Extensively Drug Resistance